Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer is a research paper published in Antioxidants (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: P01 CA217797
NIH
Grant: T32 CA148062
NIH
Grant: T32 CA78586
NCI NIH HHS
Grant: T32 CA078586
National Institutes of Health
Grant: 5P01CA217797-04
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
National Institutes of Health
Grant: 3T32CA148062-04S1
University of Iowa Surgical Oncology Research Training Program
National Institutes of Health
Grant: 3T32CA078586-05S1
TRAINING PROGRAM IN FREE RADICAL AND RADIATION BIOLOGY
FWCI
1.07
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals